Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	14-3-3 protein binding	SYNPO2 ESR1 BAD HLA-E HLA-F	1.52e-05	42	150	5	GO:0071889
GeneOntologyMolecularFunction	RNA polymerase II cis-regulatory region sequence-specific DNA binding	CUX2 ESR1 E2F7 CHD7 FOXD4L6 ZNF496 FOXD4L5 ZBTB34 ZNF34 FOXD4L4 FOXD4L1 DACH2 NFATC3 FOXD4L3 ZNF341 RORA ELF4 PAX2 TBR1 TBX20 HSF2 TCF7L1 EP300 FOXD4	1.86e-05	1244	150	24	GO:0000978
GeneOntologyMolecularFunction	cis-regulatory region sequence-specific DNA binding	CUX2 ESR1 E2F7 CHD7 FOXD4L6 ZNF496 FOXD4L5 ZBTB34 ZNF34 FOXD4L4 FOXD4L1 DACH2 NFATC3 FOXD4L3 ZNF341 RORA ELF4 PAX2 TBR1 TBX20 HSF2 TCF7L1 EP300 FOXD4	2.64e-05	1271	150	24	GO:0000987
GeneOntologyMolecularFunction	nucleoside-triphosphatase regulator activity	GARNL3 IQSEC2 OBSCN GMIP FAM13B RUNDC3A ARFGAP3 SBF2 KNDC1 FLCN HERC1 DOCK6 SMCR8 ARHGAP45	2.96e-05	507	150	14	GO:0060589
GeneOntologyMolecularFunction	GTPase regulator activity	GARNL3 IQSEC2 OBSCN GMIP FAM13B RUNDC3A ARFGAP3 SBF2 KNDC1 FLCN HERC1 DOCK6 SMCR8 ARHGAP45	2.96e-05	507	150	14	GO:0030695
GeneOntologyMolecularFunction	RNA polymerase II transcription regulatory region sequence-specific DNA binding	NCOA3 CUX2 ESR1 E2F7 ESX1 CHD7 FOXD4L6 ZNF496 FOXD4L5 ZBTB34 ZNF34 FOXD4L4 FOXD4L1 DACH2 NFATC3 FOXD4L3 ZNF341 RORA ELF4 PAX2 TBR1 TBX20 HSF2 TCF7L1 EP300 FOXD4	3.15e-05	1459	150	26	GO:0000977
GeneOntologyMolecularFunction	DNA-binding transcription factor activity, RNA polymerase II-specific	ZNF438 NCOA3 CUX2 ESR1 E2F7 ESX1 FOXD4L6 ZNF496 FOXD4L5 ZBTB34 ZNF34 FOXD4L4 FOXD4L1 DACH2 NFATC3 FOXD4L3 ZNF341 RORA ELF4 PAX2 TBR1 TBX20 HSF2 TCF7L1 FOXD4	5.08e-05	1412	150	25	GO:0000981
GeneOntologyMolecularFunction	beta-catenin binding	BCL9L ESR1 PTPRJ RORA TCF7L1 EP300	2.94e-04	120	150	6	GO:0008013
GeneOntologyBiologicalProcess	positive regulation of cellular component organization	FNIP2 ISLR2 SYNPO2 CUX2 ANK1 MAP1B ABCA13 IQSEC2 BAD AMBRA1 CUL7 CLIP1 RETREG3 PDPN CAMKK2 TTBK1 MYLK3 PTPRJ PTPRZ1 BTC ANAPC2 GOLGA8B MACF1 ATM SMCR8 IL4R EP300 GOLGA4	4.06e-07	1366	148	28	GO:0051130
GeneOntologyBiologicalProcess	regulation of neuron projection development	ISLR2 CUX2 MAP1B HLA-E HLA-F CUL7 CLIP1 RETREG3 RNF6 PTPRZ1 HECW2 ANAPC2 KNDC1 GOLGA8B MACF1 TBR1 EP300 GOLGA4	4.24e-07	612	148	18	GO:0010975
GeneOntologyBiologicalProcess	positive regulation of cell differentiation	BCL9L NCOA3 ISLR2 CUX2 MAP1B BAD LAMA1 AMBRA1 CUL7 ITPKB PDPN TTBK1 MYLK3 PTPRZ1 BTC ANAPC2 GOLGA8B MACF1 PAX2 TBX20 IL4R EP300 GOLGA4 DNMT3B	1.99e-06	1141	148	24	GO:0045597
GeneOntologyBiologicalProcess	positive regulation of axon extension	ISLR2 MAP1B ANAPC2 MACF1 EP300 GOLGA4	2.68e-06	55	148	6	GO:0045773
GeneOntologyBiologicalProcess	regulation of axon extension	ISLR2 MAP1B RNF6 ANAPC2 MACF1 EP300 GOLGA4	1.01e-05	104	148	7	GO:0030516
GeneOntologyBiologicalProcess	regulation of plasma membrane bounded cell projection organization	ISLR2 CUX2 MAP1B HLA-E HLA-F CUL7 CLIP1 RETREG3 PDPN RNF6 PTPRZ1 HECW2 ANAPC2 KNDC1 GOLGA8B MACF1 TBR1 EP300 GOLGA4	1.05e-05	846	148	19	GO:0120035
GeneOntologyBiologicalProcess	regulation of cell projection organization	ISLR2 CUX2 MAP1B HLA-E HLA-F CUL7 CLIP1 RETREG3 PDPN RNF6 PTPRZ1 HECW2 ANAPC2 KNDC1 GOLGA8B MACF1 TBR1 EP300 GOLGA4	1.38e-05	863	148	19	GO:0031344
GeneOntologyBiologicalProcess	positive regulation of axonogenesis	ISLR2 MAP1B ANAPC2 GOLGA8B MACF1 EP300 GOLGA4	1.84e-05	114	148	7	GO:0050772
GeneOntologyBiologicalProcess	regulation of extent of cell growth	ISLR2 MAP1B RNF6 ANAPC2 MACF1 EP300 GOLGA4	2.86e-05	122	148	7	GO:0061387
GeneOntologyBiologicalProcess	positive regulation of cell development	ISLR2 CUX2 MAP1B BAD AMBRA1 CUL7 ITPKB TTBK1 PTPRZ1 ANAPC2 GOLGA8B MACF1 IL4R EP300 GOLGA4	3.68e-05	614	148	15	GO:0010720
GeneOntologyBiologicalProcess	positive regulation of nervous system development	ISLR2 CUX2 MAP1B IQSEC2 CUL7 TTBK1 PTPRZ1 ANAPC2 GOLGA8B MACF1 EP300 GOLGA4	5.00e-05	418	148	12	GO:0051962
GeneOntologyBiologicalProcess	positive regulation of neurogenesis	ISLR2 CUX2 MAP1B CUL7 TTBK1 PTPRZ1 ANAPC2 GOLGA8B MACF1 EP300 GOLGA4	5.13e-05	354	148	11	GO:0050769
GeneOntologyBiologicalProcess	axon extension	ISLR2 MAP1B RNF6 ANAPC2 MACF1 EP300 GOLGA4	5.47e-05	135	148	7	GO:0048675
GeneOntologyBiologicalProcess	regulation of axonogenesis	ISLR2 MAP1B RNF6 ANAPC2 GOLGA8B MACF1 EP300 GOLGA4	7.56e-05	192	148	8	GO:0050770
GeneOntologyBiologicalProcess	plasma membrane bounded cell projection morphogenesis	ISLR2 CUX2 MAP1B LAMA1 CUL7 PDPN RNF6 PTPRZ1 HECW2 ANAPC2 KNDC1 GOLGA8B MACF1 PAX2 TBR1 EP300 GOLGA4	8.37e-05	819	148	17	GO:0120039
GeneOntologyBiologicalProcess	regulation of neurogenesis	ISLR2 CUX2 MAP1B CHD7 CUL7 TTBK1 RNF6 PTPRZ1 ANAPC2 GOLGA8B MACF1 EP300 GOLGA4	8.96e-05	515	148	13	GO:0050767
GeneOntologyBiologicalProcess	cell projection morphogenesis	ISLR2 CUX2 MAP1B LAMA1 CUL7 PDPN RNF6 PTPRZ1 HECW2 ANAPC2 KNDC1 GOLGA8B MACF1 PAX2 TBR1 EP300 GOLGA4	9.28e-05	826	148	17	GO:0048858
GeneOntologyBiologicalProcess	cell morphogenesis involved in neuron differentiation	ISLR2 CUX2 MAP1B LAMA1 CUL7 RNF6 PTPRZ1 HECW2 ANAPC2 KNDC1 GOLGA8B MACF1 PAX2 TBR1 EP300 GOLGA4	9.68e-05	748	148	16	GO:0048667
GeneOntologyBiologicalProcess	regulation of dendrite morphogenesis	CUX2 CUL7 PTPRZ1 HECW2 ANAPC2 KNDC1	9.95e-05	103	148	6	GO:0048814
GeneOntologyBiologicalProcess	regulation of dendrite development	CUX2 CUL7 CLIP1 PTPRZ1 HECW2 ANAPC2 KNDC1	1.06e-04	150	148	7	GO:0050773
GeneOntologyBiologicalProcess	small GTPase-mediated signal transduction	GARNL3 IQSEC2 OBSCN GMIP KANK2 FAM13B ITPKB PDPN RUNDC3A KNDC1 FLCN DOCK6 ARHGAP45	1.38e-04	538	148	13	GO:0007264
GeneOntologyBiologicalProcess	regulation of nervous system development	ISLR2 CUX2 MAP1B IQSEC2 CHD7 CUL7 TTBK1 RNF6 PTPRZ1 ANAPC2 GOLGA8B MACF1 EP300 GOLGA4	1.68e-04	625	148	14	GO:0051960
GeneOntologyBiologicalProcess	neuron projection morphogenesis	ISLR2 CUX2 MAP1B LAMA1 CUL7 RNF6 PTPRZ1 HECW2 ANAPC2 KNDC1 GOLGA8B MACF1 PAX2 TBR1 EP300 GOLGA4	2.15e-04	802	148	16	GO:0048812
GeneOntologyBiologicalProcess	positive regulation of cell projection organization	ISLR2 CUX2 MAP1B CUL7 CLIP1 RETREG3 PTPRZ1 ANAPC2 GOLGA8B MACF1 EP300 GOLGA4	2.39e-04	494	148	12	GO:0031346
GeneOntologyBiologicalProcess	process utilizing autophagic mechanism	SYNPO2 BAD AMBRA1 RNF213 RETREG3 CAMKK2 SBF2 FLCN GOLGA8B ZFYVE26 ATM HERC1 SMCR8 EP300	2.51e-04	650	148	14	GO:0061919
GeneOntologyBiologicalProcess	autophagy	SYNPO2 BAD AMBRA1 RNF213 RETREG3 CAMKK2 SBF2 FLCN GOLGA8B ZFYVE26 ATM HERC1 SMCR8 EP300	2.51e-04	650	148	14	GO:0006914
GeneOntologyBiologicalProcess	regulation of macrophage activation	TNIP2 TTBK1 RORA ATM IL4R	2.94e-04	81	148	5	GO:0043030
GeneOntologyBiologicalProcess	developmental growth	NCOA3 ISLR2 MAP1B ESR1 HLA-E HLA-F CHD7 GJD4 RNF6 CTR9 ANAPC2 MACF1 ATM TBX20 EP300 GOLGA4 ALPI	2.96e-04	911	148	17	GO:0048589
GeneOntologyBiologicalProcess	antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway	HLA-E HLA-F	3.04e-04	4	148	2	GO:0002488
GeneOntologyBiologicalProcess	antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent	HLA-E HLA-F	3.04e-04	4	148	2	GO:0002489
GeneOntologyBiologicalProcess	positive regulation of developmental growth	ISLR2 MAP1B CHD7 ANAPC2 MACF1 TBX20 EP300 GOLGA4	3.29e-04	238	148	8	GO:0048639
GeneOntologyBiologicalProcess	neuron projection development	ISLR2 CUX2 MAP1B LAMA1 HLA-E HLA-F CUL7 CLIP1 RETREG3 RNF6 PTPRZ1 HECW2 ANAPC2 KNDC1 GOLGA8B MACF1 PAX2 TBR1 HERC1 EP300 GOLGA4	3.43e-04	1285	148	21	GO:0031175
GeneOntologyBiologicalProcess	antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent	HLA-E HLA-F	5.04e-04	5	148	2	GO:0002481
GeneOntologyBiologicalProcess	antigen processing and presentation of exogenous peptide antigen via MHC class Ib	HLA-E HLA-F	5.04e-04	5	148	2	GO:0002477
GeneOntologyCellularComponent	chromatin	NCOA3 CUX2 ESR1 E2F7 ESX1 CHD7 FOXD4L6 FOXD4L5 ZBTB34 FOXD4L4 FOXD4L1 NFATC3 FOXD4L3 CTR9 RORA ELF4 CHD6 PAX2 TBR1 TBX20 HSF2 SMCR8 TCF7L1 EP300 FOXD4 DNMT3B	1.63e-05	1480	149	26	GO:0000785
MousePheno	anophthalmia	GARNL3 TCOF1 FOXD4L6 FOXD4L5 FOXD4L4 FOXD4L1 DACH2 FOXD4L3 PTPRZ1 FOXD4	4.71e-05	246	119	10	MP:0001293
MousePheno	decreased activated T cell number	HLA-E HLA-F ATM	4.87e-05	9	119	3	MP:0001830
MousePheno	abnormal cerebellar cortex morphology	ANK1 MAP1B CHD7 STARD9 KNDC1 MAST1 GOLGA8B RORA ZFYVE26 ATM HERC1	4.99e-05	300	119	11	MP:0004097
MousePheno	Purkinje cell degeneration	ANK1 STARD9 RORA ZFYVE26 ATM HERC1	6.47e-05	81	119	6	MP:0000876
MousePheno	abnormal cerebellar layer morphology	ANK1 MAP1B STARD9 KNDC1 MAST1 GOLGA8B RORA ZFYVE26 ATM HERC1	8.24e-05	263	119	10	MP:0009956
Domain	-	E2F7 FOXD4L6 FOXD4L5 FOXD4L4 FOXD4L1 FOXD4L3 ANAPC2 ELF4 PAX2 HSF2 FOXD4	1.34e-06	218	148	11	1.10.10.10
Domain	TF_fork_head_CS_2	FOXD4L6 FOXD4L5 FOXD4L4 FOXD4L1 FOXD4L3 FOXD4	1.61e-06	46	148	6	IPR030456
Domain	TF_fork_head_CS_1	FOXD4L6 FOXD4L5 FOXD4L4 FOXD4L1 FOXD4L3 FOXD4	1.84e-06	47	148	6	IPR018122
Domain	FH	FOXD4L6 FOXD4L5 FOXD4L4 FOXD4L1 FOXD4L3 FOXD4	2.36e-06	49	148	6	SM00339
Domain	FORK_HEAD_1	FOXD4L6 FOXD4L5 FOXD4L4 FOXD4L1 FOXD4L3 FOXD4	2.36e-06	49	148	6	PS00657
Domain	FORK_HEAD_2	FOXD4L6 FOXD4L5 FOXD4L4 FOXD4L1 FOXD4L3 FOXD4	2.36e-06	49	148	6	PS00658
Domain	Fork_head_dom	FOXD4L6 FOXD4L5 FOXD4L4 FOXD4L1 FOXD4L3 FOXD4	2.36e-06	49	148	6	IPR001766
Domain	FORK_HEAD_3	FOXD4L6 FOXD4L5 FOXD4L4 FOXD4L1 FOXD4L3 FOXD4	2.36e-06	49	148	6	PS50039
Domain	Forkhead	FOXD4L6 FOXD4L5 FOXD4L4 FOXD4L1 FOXD4L3 FOXD4	2.36e-06	49	148	6	PF00250
Domain	WHTH_DNA-bd_dom	E2F7 FOXD4L6 FOXD4L5 FOXD4L4 FOXD4L1 FOXD4L3 ANAPC2 ELF4 PAX2 HSF2 FOXD4	3.70e-06	242	148	11	IPR011991
Domain	Folliculin	FLCN SMCR8	6.24e-05	2	148	2	IPR021713
Domain	CK1gamma_C	CSNK1G3 CSNK1G1	1.86e-04	3	148	2	PF12605
Domain	Casein_kinase-1_gamma_C	CSNK1G3 CSNK1G1	1.86e-04	3	148	2	IPR022247
Domain	Protocadherin	PCDH11Y PCDH11X	6.14e-04	5	148	2	PF08374
Domain	Protocadherin	PCDH11Y PCDH11X	6.14e-04	5	148	2	IPR013585
Domain	BRK	CHD7 CHD6	9.16e-04	6	148	2	SM00592
Domain	Nuc_rcpt_coact	NCOA3 EP300	9.16e-04	6	148	2	IPR009110
Domain	MHC_I_a_C	HLA-E HLA-F	9.16e-04	6	148	2	IPR010579
Domain	BRK_domain	CHD7 CHD6	9.16e-04	6	148	2	IPR006576
Domain	MHC_I_C	HLA-E HLA-F	9.16e-04	6	148	2	PF06623
Domain	BRK	CHD7 CHD6	9.16e-04	6	148	2	PF07533
Pubmed	Neural transcription factors bias cleavage stage blastomeres to give rise to neural ectoderm.	FOXD4L6 FOXD4L5 FOXD4L4 FOXD4L1 FOXD4L3 FOXD4	7.11e-15	6	155	6	27092474
Pubmed	Strain-specific modifier genes of Cecr2-associated exencephaly in mice: genetic analysis and identification of differentially expressed candidate genes.	FOXD4L6 FOXD4L5 FOXD4L4 FOXD4L1 FOXD4L3 PAX2 FOXD4	1.90e-13	15	155	7	22045912
Pubmed	The mouse fkh-2 gene. Implications for notochord, foregut, and midbrain regionalization.	FOXD4L6 FOXD4L5 FOXD4L4 FOXD4L1 FOXD4L3 FOXD4	1.98e-13	8	155	6	8530406
Pubmed	Expression of the winged helix genes fkh-4 and fkh-5 defines domains in the central nervous system.	FOXD4L6 FOXD4L5 FOXD4L4 FOXD4L1 FOXD4L3 RORA FOXD4	3.37e-13	16	155	7	8861101
Pubmed	An amphioxus winged helix/forkhead gene, AmphiFoxD: insights into vertebrate neural crest evolution.	FOXD4L6 FOXD4L5 FOXD4L4 FOXD4L1 FOXD4L3 FOXD4	5.91e-13	9	155	6	12412011
Pubmed	Functional equivalency between Otx2 and Otx1 in development of the rostral head.	FOXD4L6 FOXD4L5 FOXD4L4 FOXD4L1 FOXD4L3 PAX2 FOXD4	1.47e-12	19	155	7	9895322
Pubmed	Sequential roles for Otx2 in visceral endoderm and neuroectoderm for forebrain and midbrain induction and specification.	FOXD4L6 FOXD4L5 FOXD4L4 FOXD4L1 FOXD4L3 PAX2 FOXD4	3.36e-12	21	155	7	9449667
Pubmed	A genetic study of the suppressors of the Engrailed-1 cerebellar phenotype.	FOXD4L6 FOXD4L5 FOXD4L4 FOXD4L1 FOXD4L3 FOXD4	1.19e-11	13	155	6	16884697
Pubmed	Cloning and characterization of seven human forkhead proteins: binding site specificity and DNA bending.	FOXD4L6 FOXD4L5 FOXD4L4 FOXD4L1 FOXD4L3 FOXD4	1.19e-11	13	155	6	7957066
Pubmed	Six members of the mouse forkhead gene family are developmentally regulated.	FOXD4L6 FOXD4L5 FOXD4L4 FOXD4L1 FOXD4L3 FOXD4	3.44e-11	15	155	6	7689224
Pubmed	Developmental competence of the gut endoderm: genetic potentiation by GATA and HNF3/fork head proteins.	FOXD4L6 FOXD4L5 FOXD4L4 FOXD4L1 FOXD4L3 FOXD4	5.49e-11	16	155	6	10208738
Pubmed	Forkhead transcription factor Foxf2 (LUN)-deficient mice exhibit abnormal development of secondary palate.	FOXD4L6 FOXD4L5 FOXD4L4 FOXD4L1 FOXD4L3 FOXD4	2.62e-10	20	155	6	12812790
Pubmed	Crucial roles of Foxa2 in mouse anterior-posterior axis polarization via regulation of anterior visceral endoderm-specific genes.	FOXD4L6 FOXD4L5 FOXD4L4 FOXD4L1 FOXD4L3 FOXD4	5.00e-10	22	155	6	17389379
Pubmed	Otx2 is required to respond to signals from anterior neural ridge for forebrain specification.	FOXD4L6 FOXD4L5 FOXD4L4 FOXD4L1 FOXD4L3 FOXD4	8.95e-10	24	155	6	11820816
Pubmed	A Requirement for Zic2 in the Regulation of Nodal Expression Underlies the Establishment of Left-Sided Identity.	FOXD4L6 FOXD4L5 FOXD4L4 FOXD4L1 FOXD4L3 FOXD4	8.95e-10	24	155	6	29992973
Pubmed	Ssdp1 regulates head morphogenesis of mouse embryos by activating the Lim1-Ldb1 complex.	FOXD4L6 FOXD4L5 FOXD4L4 FOXD4L1 FOXD4L3 FOXD4	1.52e-09	26	155	6	15857913
Pubmed	FOXD4a and FOXD4b, two new winged helix transcription factors, are expressed in human leukemia cell lines.	FOXD4L6 FOXD4L5 FOXD4L4 FOXD4	1.89e-09	5	155	4	12234674
Pubmed	Screening large numbers of expression patterns of transcription factors in late stages of the mouse thymus.	NCOA3 ESR1 ESX1 FOXD4L6 FOXD4L5 FOXD4L4 FOXD4L1 FOXD4L3 ELF4 PAX2 TCF7L1 FOXD4	2.71e-09	263	155	12	20932939
Pubmed	Molecular profiling of synovial joints: use of microarray analysis to identify factors that direct the development of the knee and elbow.	FOXD4L6 FOXD4L5 FOXD4L4 FOXD4L1 FOXD4L3 FOXD4	3.10e-09	29	155	6	22972626
Pubmed	Genome-scale study of transcription factor expression in the branching mouse lung.	NAB1 FOXD4L6 FOXD4L5 FOXD4L4 FOXD4L1 FOXD4L3 FOXD4	2.12e-08	67	155	7	22711520
Pubmed	Gene content and function of the ancestral chromosome fusion site in human chromosome 2q13-2q14.1 and paralogous regions.	FOXD4L4 FOXD4L1 FOXD4L3 FOXD4	1.22e-07	11	155	4	12421752
Pubmed	A census of human transcription factors: function, expression and evolution.	NCOA3 CUX2 ESR1 E2F7 ESX1 FOXD4L4 FOXD4L1 DACH2 NFATC3 FOXD4L3 RORA ELF4 PAX2 TBR1 TBX20 HSF2 TCF7L1 FOXD4	1.41e-07	908	155	18	19274049
Pubmed	Exome sequencing in seven families and gene-based association studies indicate genetic heterogeneity and suggest possible candidates for fibromuscular dysplasia.	DYNC2H1 OBSCN RNF213	3.46e-07	4	155	3	26147384
Pubmed	Structural Insights of Transcriptionally Active, Full-Length Androgen Receptor Coactivator Complexes.	NCOA3 ESR1 EP300	3.46e-07	4	155	3	32668201
Pubmed	Absence of layer-specific cadherin expression profiles in the neocortex of the reeler mutant mouse.	CUX2 PCDH11Y PCDH11X TBR1	3.67e-07	14	155	4	20847152
Pubmed	Prediction of the coding sequences of unidentified human genes. XVI. The complete sequences of 150 new cDNA clones from brain which code for large proteins in vitro.	CHD7 NHSL1 STARD9 HECW2 ANAPC2 PCDH11X CHD6 DOCK6	4.65e-07	153	155	8	10718198
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	MAGEA8 SYNPO2 CUX2 TCOF1 ESR1 CHD7 C6orf132 XIRP2 MDC1 WDR90 ATM DNMT3B	5.79e-07	430	155	12	35044719
Pubmed	Ligand-independent interactions of p160/steroid receptor coactivators and CREB-binding protein (CBP) with estrogen receptor-alpha: regulation by phosphorylation sites in the A/B region depends on other receptor domains.	NCOA3 ESR1 EP300	8.63e-07	5	155	3	12714702
Pubmed	Fbxo22-mediated KDM4B degradation determines selective estrogen receptor modulator activity in breast cancer.	NCOA3 ESR1 EP300	8.63e-07	5	155	3	30418174
Pubmed	Structure of a biologically active estrogen receptor-coactivator complex on DNA.	NCOA3 ESR1 EP300	8.63e-07	5	155	3	25728767
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	KMT2B ANK1 IQSEC2 LAMA1 OBSCN IGDCC3 ESX1 RNF213 MAGI3 SH2D2A FBXO10 HECW2 CHD6 ATM TBR1	1.17e-06	736	155	15	29676528
Pubmed	Activation of rapid oestrogen signalling in aggressive human breast cancers.	NCOA3 ESR1 EP300	1.72e-06	6	155	3	23065768
Pubmed	Signaling within a coactivator complex: methylation of SRC-3/AIB1 is a molecular switch for complex disassembly.	NCOA3 ESR1 EP300	1.72e-06	6	155	3	16923966
Pubmed	Structural and Functional Impacts of ER Coactivator Sequential Recruitment.	NCOA3 ESR1 EP300	1.72e-06	6	155	3	28844863
Pubmed	Embryonic origins of ZebrinII parasagittal stripes and establishment of topographic Purkinje cell projections.	RORA PAX2 TBR1	1.72e-06	6	155	3	19150487
Pubmed	Proteomic analysis of steady-state nuclear hormone receptor coactivator complexes.	NCOA3 NFATC3 MDC1 HERC1 EP300 GOLGA3	2.33e-06	85	155	6	16051665
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	KMT2B OBSCN TRMT1 AMBRA1 C6orf132 NHSL1 ZNF341 SBF2 FLCN KCNQ2 ZFYVE26 PAX2 WDR90 HERC1 DOCK6 ANKRD33B IL4R EP300	2.35e-06	1105	155	18	35748872
Pubmed	Diverse fates of paralogs following segmental duplication of telomeric genes.	FOXD4L4 FOXD4L1 FOXD4L3 FOXD4	2.61e-06	22	155	4	15233989
Pubmed	Regulation of hormone-induced histone hyperacetylation and gene activation via acetylation of an acetylase.	NCOA3 ESR1 EP300	4.78e-06	8	155	3	10490106
Pubmed	PCR-generated cDNA libraries from reduced numbers of mouse oocytes.	HLA-E HLA-F HSF2	7.15e-06	9	155	3	8903793
Pubmed	Microarray analysis of Foxa2 mutant mouse embryos reveals novel gene expression and inductive roles for the gastrula organizer and its derivatives.	IGDCC3 CHD7 FOXD4L6 FOXD4L5 FOXD4L4 FOXD4L1 FOXD4L3 ATM FOXD4	1.03e-05	306	155	9	18973680
Pubmed	CBP-HSF2 structural and functional interplay in Rubinstein-Taybi neurodevelopmental disorder.	TBR1 HSF2 EP300	1.40e-05	11	155	3	36385105
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	MIER2 DYNC2H1 RNF213 MAGI3 CUL7 ZBTB34 TTBK1 SBF2 FAM169A MACF1 HERPUD1	1.44e-05	493	155	11	15368895
Pubmed	Common genetic variation in candidate genes and susceptibility to subtypes of breast cancer.	ESR1 FBXO10 PTPRJ ATM EP300 DNMT3B	1.48e-05	117	155	6	19124506
Pubmed	Estrogen receptor alpha/co-activator interaction assay: TR-FRET.	NCOA3 ESR1	1.97e-05	2	155	2	25859975
Pubmed	Localization of ank1.5 in the sarcoplasmic reticulum precedes that of SERCA and RyR: relationship with the organization of obscurin in developing sarcomeres.	ANK1 OBSCN	1.97e-05	2	155	2	19002483
Pubmed	Endogenously expressed estrogen receptor and coactivator AIB1 interact in MCF-7 human breast cancer cells.	NCOA3 ESR1	1.97e-05	2	155	2	11050174
Pubmed	Interplay between the DNA damage proteins MDC1 and ATM in the regulation of the spindle assembly checkpoint.	MDC1 ATM	1.97e-05	2	155	2	24509855
Pubmed	Interaction between p230 and MACF1 is associated with transport of a glycosyl phosphatidyl inositol-anchored protein from the Golgi to the cell periphery.	MACF1 GOLGA4	1.97e-05	2	155	2	15265687
Pubmed	Coactivator AIB1 links estrogen receptor transcriptional activity and stability.	NCOA3 ESR1	1.97e-05	2	155	2	15289619
Pubmed	Conservation of PCDHX in mammals; expression of human X/Y genes predominantly in brain.	PCDH11Y PCDH11X	1.97e-05	2	155	2	11003707
Pubmed	Pcdh11x Negatively Regulates Dendritic Branching.	PCDH11Y PCDH11X	1.97e-05	2	155	2	25687328
Pubmed	PAX2 promoter methylation and AIB1 overexpression promote tamoxifen resistance in breast carcinoma patients.	NCOA3 PAX2	1.97e-05	2	155	2	33509057
Pubmed	Obscurin is a ligand for small ankyrin 1 in skeletal muscle.	ANK1 OBSCN	1.97e-05	2	155	2	12631729
Pubmed	Estrogen-dependent and estrogen-independent mechanisms contribute to AIB1-mediated tumor formation.	NCOA3 ESR1	1.97e-05	2	155	2	20442283
Pubmed	Regulation of SRC-3 intercompartmental dynamics by estrogen receptor and phosphorylation.	NCOA3 ESR1	1.97e-05	2	155	2	17646391
Pubmed	Apigenin inhibits antiestrogen-resistant breast cancer cell growth through estrogen receptor-alpha-dependent and estrogen receptor-alpha-independent mechanisms.	NCOA3 ESR1	1.97e-05	2	155	2	18645020
Pubmed	Cadherin expression delineates the divisions of the postnatal and adult mouse amygdala.	PCDH11Y PCDH11X	1.97e-05	2	155	2	22592879
Pubmed	Mapping the binding site on small ankyrin 1 for obscurin.	ANK1 OBSCN	1.97e-05	2	155	2	17720975
Pubmed	Protocadherin X ( PCDHX) and Y ( PCDHY) genes; multiple mRNA isoforms encoding variant signal peptides and cytoplasmic domains.	PCDH11Y PCDH11X	1.97e-05	2	155	2	14727141
Pubmed	HLA-E and HLA-F Are Overexpressed in Glioblastoma and HLA-E Increased After Exposure to Ionizing Radiation.	HLA-E HLA-F	1.97e-05	2	155	2	35181585
Pubmed	Alleles of the estrogen receptor alpha-gene and an estrogen receptor cotranscriptional activator gene, amplified in breast cancer-1 (AIB1), are associated with quantitative calcaneal ultrasound.	NCOA3 ESR1	1.97e-05	2	155	2	11092404
Pubmed	Lack of association between protocadherin 11-X/Y (PCDH11X and PCDH11Y) polymorphisms and late onset Alzheimer's disease.	PCDH11Y PCDH11X	1.97e-05	2	155	2	21276771
Pubmed	Transient estrogen receptor binding and p300 redistribution support a squelching mechanism for estradiol-repressed genes.	ESR1 EP300	1.97e-05	2	155	2	25051172
Pubmed	HLA-F complex without peptide binds to MHC class I protein in the open conformer form.	HLA-E HLA-F	1.97e-05	2	155	2	20483783
Pubmed	Accelerated evolution of Protocadherin11X/Y: a candidate gene-pair for cerebral asymmetry and language.	PCDH11Y PCDH11X	1.97e-05	2	155	2	16874762
Pubmed	PCDH11 is X/Y homologous in Homo sapiens but not in Gorilla gorilla and Pan troglodytes.	PCDH11Y PCDH11X	1.97e-05	2	155	2	16825765
Pubmed	Trichostatin A enhances acetylation as well as protein stability of ERalpha through induction of p300 protein.	ESR1 EP300	1.97e-05	2	155	2	20388208
Pubmed	The protocadherin 11X/Y (PCDH11X/Y) gene pair as determinant of cerebral asymmetry in modern Homo sapiens.	PCDH11Y PCDH11X	1.97e-05	2	155	2	23600975
Pubmed	A comparative analysis of the pig, mouse, and human PCDHX genes.	PCDH11Y PCDH11X	1.97e-05	2	155	2	15112107
Pubmed	Protocadherin 11X/Y a human-specific gene pair: an immunohistochemical survey of fetal and adult brains.	PCDH11Y PCDH11X	1.97e-05	2	155	2	22744706
Pubmed	AIB1:ERα transcriptional activity is selectively enhanced in aromatase inhibitor-resistant breast cancer cells.	NCOA3 ESR1	1.97e-05	2	155	2	22550166
Pubmed	Altered AIB1 or AIB1Δ3 expression impacts ERα effects on mammary gland stromal and epithelial content.	NCOA3 ESR1	1.97e-05	2	155	2	21292825
Pubmed	Autophosphorylation at serine 1981 stabilizes ATM at DNA damage sites.	MDC1 ATM	1.97e-05	2	155	2	20026654
Pubmed	Amphipathic benzenes are designed inhibitors of the estrogen receptor alpha/steroid receptor coactivator interaction.	NCOA3 ESR1	1.97e-05	2	155	2	18484708
Pubmed	Quantitative analysis of alternative transcripts of human PCDH11X/Y genes.	PCDH11Y PCDH11X	1.97e-05	2	155	2	19859901
Pubmed	Identification of novel estrogen receptor alpha antagonists.	NCOA3 ESR1	1.97e-05	2	155	2	15145444
Pubmed	Human leukocyte antigen (HLA)-E and HLA-F expression in gastric cancer.	HLA-E HLA-F	1.97e-05	2	155	2	25862890
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	CASC3 MAP1B IQSEC2 BAD MAGI3 C6orf132 ITPKB NHSL1 MYLK3 NFATC3 STARD9 MACF1 DOCK6 GOLGA4	3.38e-05	861	155	14	36931259
Pubmed	MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development.	MAP1B TCOF1 DYNC2H1 CHD7 TRIM56 MDC1 MACF1 PAX2 EP300	3.53e-05	358	155	9	32460013
Pubmed	Polynucleotide kinase-phosphatase enables neurogenesis via multiple DNA repair pathways to maintain genome stability.	PAX2 ATM TBR1	3.80e-05	15	155	3	26290337
Pubmed	Transcription factors and nuclear receptors interact with the SWI/SNF complex through the BAF60c subunit.	ESR1 RORA EP300	3.80e-05	15	155	3	14701856
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	NCOA3 KMT2B TCOF1 CHD7 CLIP1 IWS1 TUBGCP6 CTR9 MDC1 ATM KLHDC4 GOLGA4 ALPI	4.69e-05	774	155	13	15302935
Pubmed	Spatially restricted and developmentally dynamic expression of engrailed genes in multiple cerebellar cell types.	RORA PAX2 TBR1	5.64e-05	17	155	3	21431469
Pubmed	The expression pattern of nuclear receptors during cerebellar development.	ESR1 RORA PAX2	5.64e-05	17	155	3	17205580
Pubmed	Autism risk gene POGZ promotes chromatin accessibility and expression of clustered synaptic genes.	PCDH11Y PCDH11X TBR1	5.64e-05	17	155	3	34879283
Pubmed	NCOA3 is a selective co-activator of estrogen receptor α-mediated transactivation of PLAC1 in MCF-7 breast cancer cells.	NCOA3 ESR1	5.90e-05	3	155	2	24304549
Pubmed	ANCCA, an estrogen-regulated AAA+ ATPase coactivator for ERalpha, is required for coregulator occupancy and chromatin modification.	NCOA3 ESR1	5.90e-05	3	155	2	17998543
Pubmed	BRCA1 regulates acetylation and ubiquitination of estrogen receptor-alpha.	ESR1 EP300	5.90e-05	3	155	2	19887647
Pubmed	The majority of H2-M3 is retained intracellularly in a peptide-receptive state and traffics to the cell surface in the presence of N-formylated peptides.	HLA-E HLA-F	5.90e-05	3	155	2	10430630
Pubmed	Expression of estrogen receptors, androgen receptor and steroid receptor coactivator-3 is negatively correlated to the differentiation of astrocytic tumors.	NCOA3 ESR1	5.90e-05	3	155	2	24680642
Pubmed	Structure-function evaluation of ER alpha and beta interplay with SRC family coactivators. ER selective ligands.	NCOA3 ESR1	5.90e-05	3	155	2	11389589
Pubmed	Killer-cell immunoglobulin-like receptors and falciparum malaria in southwest Nigeria.	KIR2DS3 KIR2DS5	5.90e-05	3	155	2	24929143
Pubmed	Characterization of a new subfamily of class I genes in the H-2 complex of the mouse.	HLA-E HLA-F	5.90e-05	3	155	2	3378834
Pubmed	Ring finger protein 6 promotes breast cancer cell proliferation by stabilizing estrogen receptor alpha.	ESR1 RNF6	5.90e-05	3	155	2	28223545
Pubmed	The transcriptional co-activator p/CIP (NCoA-3) is up-regulated by STAT6 and serves as a positive regulator of transcriptional activation by STAT6.	NCOA3 EP300	5.90e-05	3	155	2	15145939
Pubmed	Reduced expression of the murine HLA-G homolog Qa-2 is associated with malignancy, epithelial-mesenchymal transition and stemness in breast cancer cells.	HLA-E HLA-F	5.90e-05	3	155	2	28740236
Pubmed	Comparative genomic aspects of rat, mouse and human MHC class I gene regions.	HLA-E HLA-F	5.90e-05	3	155	2	11173841
Pubmed	Removal of Qa-2 antigen alters the Ped gene phenotype of preimplantation mouse embryos.	HLA-E HLA-F	5.90e-05	3	155	2	1327207
Pubmed	Estrogen receptor alpha represses transcription of early target genes via p300 and CtBP1.	ESR1 EP300	5.90e-05	3	155	2	19188451
Cytoband	9q21.11	FOXD4L6 FOXD4L5 FOXD4L4 FOXD4L3	3.20e-06	30	155	4	9q21.11
Cytoband	Xq21.3	DACH2 PCDH11X	2.35e-04	7	155	2	Xq21.3
GeneFamily	Guanylate cyclase receptors\|DENN/MADD domain containing	FNIP2 SBF2 FLCN SMCR8	6.13e-06	25	88	4	504
GeneFamily	Non-clustered protocadherins	PCDH11Y PCDH11X	1.50e-03	12	88	2	21
GeneFamily	Rho GTPase activating proteins\|BCH domain containing	GMIP FAM13B ARHGAP45	1.85e-03	50	88	3	721
GeneFamily	GATA zinc finger domain containing\|Myb/SANT domain containing	MIER2 CHD7 CHD6	2.19e-03	53	88	3	532
GeneFamily	Zinc fingers ZZ-type\|Lysine acetyltransferases	NCOA3 EP300	3.04e-03	17	88	2	486
GeneFamily	CD molecules\|Killer cell immunoglobulin like receptors	KIR2DS3 KIR2DS5	3.41e-03	18	88	2	620
GeneFamily	T-boxes	TBR1 TBX20	3.41e-03	18	88	2	766
GeneFamily	Protein tyrosine phosphatases, receptor type	PTPRJ PTPRZ1	4.63e-03	21	88	2	813
Coexpression	MORI_MATURE_B_LYMPHOCYTE_UP	HLA-E HLA-F FOXD4L6 FOXD4L5 FOXD4L4 FOXD4L1 MFSD14B FOXD4L3 MACF1 FOXD4	7.18e-10	106	154	10	MM595
Coexpression	MIKKELSEN_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3	LAMA1 FOXD4L6 FOXD4L5 FOXD4L4 FOXD4L1 FOXD4L3 KNDC1 ANKRD33B FOXD4	5.80e-06	217	154	9	MM861
Coexpression	GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP	KMT2B CHD7 IWS1 MACF1 PRR14L ATM HERC1 EP300	1.18e-05	180	154	8	M8239
Coexpression	LEE_EARLY_T_LYMPHOCYTE_DN	HLA-E HLA-F PTPRJ ATM IL4R	2.34e-05	58	154	5	M13767
CoexpressionAtlas	dev gonad_e13.5_F_DevVascOvary_Flk_k-means-cluster#4_top-relative-expression-ranked_1000	ITPKB NHSL1 STARD9 MACF1 ELF4 IL4R DNMT3B	5.39e-08	51	145	7	gudmap_dev gonad_e13.5_F_gudmap_devVascOvary_Flk_k4_1000
CoexpressionAtlas	dev gonad_e12.5_M_SertoliCell_Sox9_k-means-cluster#4_top-relative-expression-ranked_1000	CHD7 ITPKB NHSL1 HECW2 DNMT3B	1.21e-05	44	145	5	gudmap_dev gonad_e12.5_M_SertoliCell_Sox9_k4_1000
ToppCell	wk_15-18-Hematologic-Myeloid-aDC_1\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	HLA-F FOXD4L6 ITIH1 FOXD4L5 FOXD4L4 FOXD4L1 FOXD4L3 ANKRD33B FOXD4	1.13e-08	177	153	9	ccf5dc54780d6039a4d062dee88440c011ddc0a3
ToppCell	5'-GW_trimst-2-LymphNode-Hematopoietic-Myeloid-Lymphoid_DC\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PAGE2 FOXD4L6 ITIH1 FOXD4L4 FOXD4L1 FOXD4L3 ANKRD33B FOXD4	1.25e-07	168	153	8	6dd58fd981750da49afd53796f244e1803cce97f
ToppCell	wk_20-22-Hematologic-Myeloid-aDC_1\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	TNIP2 FOXD4L6 ITIH1 FOXD4L4 FOXD4L1 FOXD4L3 ANKRD33B FOXD4	1.95e-07	178	153	8	fd2bdb4796e86c8cff2d25f0c730ffea21db8787
ToppCell	severe-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	RNF213 FAM169A GOLGA8B MACF1 RORA ATM HERC1 GOLGA4	4.21e-07	197	153	8	57ebd552f10d6278623b52a3d484d4b91ae1d028
ToppCell	PBMC-Mild-Lymphocyte-T/NK-Other_T-gd_T-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	BCL9L HLA-E RNF213 SH2D2A MACF1 RORA ATM PDZD4	4.38e-07	198	153	8	a1b310274aa9b3d2aa1fe9488d67422bf4ac81d2
ToppCell	PBMC-Mild-Lymphocyte-T/NK-Other_T-gd_T\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	BCL9L HLA-E RNF213 SH2D2A MACF1 RORA ATM PDZD4	4.38e-07	198	153	8	76aff381403bc5a8a9cc73eb1e5dbdc0bac7de6c
ToppCell	PBMC-Mild-Lymphocyte-T/NK-Other_T-gd_T\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	BCL9L HLA-E RNF213 SH2D2A MACF1 RORA ATM PDZD4	4.38e-07	198	153	8	a781fd35a7cda8b7760c2e3ddccaac7aac26c979
ToppCell	PBMC-Mild-Lymphocyte-T/NK-Other_T-gd_T-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	BCL9L HLA-E RNF213 SH2D2A MACF1 RORA ATM PDZD4	4.38e-07	198	153	8	df399674345c45738d765a8354ea8d1484572c34
ToppCell	COVID-19_Mild-Lymphoid_T/NK-gd_T\|COVID-19_Mild / Disease group, lineage and cell class	BCL9L HLA-E RNF213 SH2D2A MACF1 RORA ATM PDZD4	4.38e-07	198	153	8	6aea5d00c417708f05b6d2dfe5a962d80864f8eb
ToppCell	COVID-19-COVID-19_Mild-Lymphocyte-T/NK-gd_T\|COVID-19_Mild / Disease, condition lineage and cell class	BCL9L HLA-E RNF213 SH2D2A MACF1 RORA ATM PDZD4	4.72e-07	200	153	8	6560753d3df2f87860b52052d4881aa45410f666
ToppCell	5'-GW_trimst-1.5-LargeIntestine-Neuronal\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ISLR2 MAP1B RUNDC3B CHD7 RUNDC3A PTPRZ1 KCNQ2 JPT1	4.72e-07	200	153	8	51d20543a9c9330c34c085d9290a1fc8b5bff0d4
ToppCell	mild-gd_T\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	BCL9L HLA-F RNF213 MACF1 RORA ATM GOLGA4 PDZD4	4.72e-07	200	153	8	109f673a4967ffa52270a0b4f818b3461288db44
ToppCell	facs-Heart-RV-24m-Mesenchymal-ventricular_myocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ARPP21 ANK1 OBSCN MYLK3 XIRP2 SUN3 CFAP46	2.71e-06	177	153	7	692cd03bf0958ebeec34d41bfe87713a768e9a8e
ToppCell	facs-Heart-RV-24m-Mesenchymal-ventricular_cardiomyocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ARPP21 ANK1 OBSCN MYLK3 XIRP2 SUN3 CFAP46	2.71e-06	177	153	7	c08583ea68bbeb6b5de852a46b0c0f04792dae55
ToppCell	3'-GW_trimst-2-SmallIntestine-Neuronal-neurons_A-Branch_A4_(IN)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ISLR2 CUX2 ARPP21 GARNL3 MAP1B RUNDC3B RUNDC3A	3.14e-06	181	153	7	fb4df9a128761abe5c6310a30d7b2f7f2fdef46d
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANK1 ABCA13 LAMA1 OBSCN XIRP2 PCDH11X KCNQ2	3.50e-06	184	153	7	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANK1 ABCA13 LAMA1 OBSCN XIRP2 PCDH11X KCNQ2	3.50e-06	184	153	7	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANK1 ABCA13 LAMA1 OBSCN XIRP2 PCDH11X KCNQ2	3.50e-06	184	153	7	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	5'-GW_trimst-1.5-LargeIntestine-Neuronal-neurons_A-Branch_A3_(IPAN/IN)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CACNA1E ISLR2 ARPP21 MAP1B RUNDC3B MAST1 PAX2	3.62e-06	185	153	7	110d5f02759c8235b14aea524ea47199696094ea
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_A-Branch_A1_(iMN)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ARPP21 GARNL3 MAP1B RUNDC3B CHD7 RUNDC3A JPT1	4.63e-06	192	153	7	fe9297cb65234d9f511bab1a5dbf2679d5a4cd15
ToppCell	severe-low-quality_cells\|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	RNF213 FAM169A GOLGA8B MACF1 RORA ATM HERC1	4.79e-06	193	153	7	9337bc93e3904c7fc7c93c328518bcd6453b1e8c
ToppCell	PBMC-Severe-Lymphocyte-T/NK-CD8+_T\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HLA-E HLA-F RNF213 MACF1 RORA ATM PDZD4	5.30e-06	196	153	7	0f3c7fd450aaa1f866b8558692534c0ea2a34e75
ToppCell	PBMC-Severe-Lymphocyte-T/NK-CD8+_T\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	HLA-E HLA-F RNF213 MACF1 RORA ATM PDZD4	5.30e-06	196	153	7	4e1f8828413896ab8a4ec92a89d6789e8e37e05a
ToppCell	COVID_non-vent-Lymphocytic-T_cell-CD8+_Memory_T_cell\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	BCL9L HLA-E RNF213 MACF1 RORA ATM PDZD4	5.48e-06	197	153	7	836061acd7f0d5de89b16f52ec679bdf09eac9db
ToppCell	Control-Control-Lymphocyte-T/NK-NK_activated\|Control / Disease, condition lineage and cell class	ESR1 RNF213 ITPKB TLDC2 MACF1 HERC1 TCF7L1	5.66e-06	198	153	7	76d5fe4e5bbe6c73a6ca409b80b5c3924e07cab7
ToppCell	systemic_lupus_erythematosus-flare\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	TCOF1 HLA-E RNF213 MACF1 RORA ATM ARHGAP45	5.66e-06	198	153	7	4c93ee921d56132d80832d8e94563f32ccf13bbc
ToppCell	healthy_donor-Lymphocytic-ILC-NK_cell\|healthy_donor / Disease condition, Lineage, Cell class and subclass	HLA-E RNF213 SH2D2A MACF1 RORA ATM PDZD4	5.66e-06	198	153	7	d7053a898e04478c577381085f615edaad3cdc5b
ToppCell	healthy_donor-Lymphocytic-ILC\|healthy_donor / Disease condition, Lineage, Cell class and subclass	HLA-E RNF213 SH2D2A MACF1 RORA ATM PDZD4	5.66e-06	198	153	7	aa33be29e26f1b8facfc894413099083ae3bbb1b
ToppCell	mild-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	RNF213 GOLGA8B MACF1 RORA ATM HERC1 GOLGA4	5.85e-06	199	153	7	f0b0097df0026496470a80d8cc9375ffd8389b00
ToppCell	COVID_non-vent-Lymphocytic-ILC\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	HLA-E RNF213 SH2D2A MACF1 RORA ATM PDZD4	5.85e-06	199	153	7	df4f7d5be099e3e6054f3b812ccf70251664e4c0
ToppCell	COVID_non-vent-Lymphocytic-ILC-NK_cell\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	HLA-E RNF213 SH2D2A MACF1 RORA ATM PDZD4	5.85e-06	199	153	7	ed35d747f11f6ea6a5cb7061057f0a98d9e0db99
ToppCell	mild-CD8+_Tem\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	BCL9L HLA-F RNF213 MACF1 RORA ATM GOLGA4	6.05e-06	200	153	7	d8aec4904c9420b8f9d7508658ba1e36c66cdfcc
ToppCell	Control-Control-Lymphocyte-T/NK-NK\|Control / Disease, condition lineage and cell class	HLA-E RNF213 SH2D2A MACF1 RORA ATM PDZD4	6.05e-06	200	153	7	c64c27dbf4df42ca2ad2bd94b50fab87b4050ef3
ToppCell	healthy_donor\|World / Disease condition, Lineage, Cell class and subclass	HLA-E HLA-F GOLGA8B MACF1 ATM ARHGAP45 PDZD4	6.05e-06	200	153	7	afd4d5609adaa470e3d880f8be4a4d55e162b3d6
ToppCell	mild-NK\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	HLA-F RNF213 SH2D2A MACF1 RORA ATM PDZD4	6.05e-06	200	153	7	a11fb1d7e124c352eb73fea0e0ec0fed577c97f7
ToppCell	COVID-19-COVID-19_Severe-Lymphocyte-T/NK-gd_T\|COVID-19_Severe / Disease, condition lineage and cell class	HLA-E HLA-F RNF213 MACF1 RORA ATM PDZD4	6.05e-06	200	153	7	f72bc3f6606ae77fe1b0a972e35b3ce0727804d9
ToppCell	Children_(3_yrs)-Epithelial-ciliated_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CACNA1E C1orf87 E2F7 PDPN PAX2 UBXN10	1.44e-05	152	153	6	854c841c1fc6300b7e9be9c98cbf9b0ce2678690
ToppCell	(7)_MNP-(7)_DC_activated\|(7)_MNP / Spleen cell shreds - cell class (v1) and cell subclass (v1)	SYNPO2 ITIH1 FOXD4L1 KCNQ2 ANKRD33B FOXD4	2.72e-05	170	153	6	4ab495b38a071fa8207331df2ce0d78a2dcd034e
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SYNPO2 ARPP21 PCDH11Y PCDH11X TBR1 ANKRD33B	3.09e-05	174	153	6	e4d65fe121a32ac4cdd6312e7b8f867f0852e991
ToppCell	PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HLA-E RNF213 RETREG3 MACF1 ARHGAP45 PDZD4	3.41e-05	177	153	6	d3e6c768b88b7906f3c7fdd00ba20842212c14b1
ToppCell	PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HLA-E RNF213 RETREG3 MACF1 ARHGAP45 PDZD4	3.41e-05	177	153	6	f8f101c772c043636bedd6b2ec81409b1d2599bf
ToppCell	COVID-19_Mild-Lymphoid_T/NK-NK_activated\|COVID-19_Mild / Disease group, lineage and cell class	HLA-E RNF213 RETREG3 MACF1 ARHGAP45 PDZD4	3.41e-05	177	153	6	6978a22fef40c8b455342373abe7593f5ede0fa4
ToppCell	PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	HLA-E RNF213 RETREG3 MACF1 ARHGAP45 PDZD4	3.41e-05	177	153	6	936ab2b180a052387124f68d0c7f41c0b164e748
ToppCell	PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	HLA-E RNF213 RETREG3 MACF1 ARHGAP45 PDZD4	3.41e-05	177	153	6	d5aeda113afaa2425874394610344570c9078478
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature-ENCC/glia_Progenitor\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CHD7 PTPRZ1 FAM169A KCNQ2 SMCR8 PDZD4	3.74e-05	180	153	6	c72f15763ba707189e29c85db533557f01c7fdb1
ToppCell	BAL-Mild-Myeloid-cDC-cDC-cDC_10\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	FOXD4L5 FOXD4L4 FOXD4L1 FOXD4L3 ANKRD33B FOXD4	3.74e-05	180	153	6	32d871738a24071b70084a7e80148a516110c78b
ToppCell	BAL-Mild-Myeloid-cDC-cDC-cDC_10\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	FOXD4L5 FOXD4L4 FOXD4L1 FOXD4L3 ANKRD33B FOXD4	3.74e-05	180	153	6	067ca8a15228c7f3b3bc7aecbc9b1611ca05e176
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_B-Branch_B1_(eMN)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CUX2 ARPP21 GARNL3 MAP1B CHD7 RUNDC3A	3.86e-05	181	153	6	7f99002a6411117cc2361334c7c9228e20c574b4
ToppCell	COVID-19_Mild-NK_activated\|COVID-19_Mild / Disease condition and Cell class	HLA-E RNF213 RETREG3 MFSD14B MACF1 ARHGAP45	4.10e-05	183	153	6	22bd05135906d0ecc4ba8c2e0a666093d1bf3b8f
ToppCell	NS-moderate-d_16-33-Epithelial-Ciliated\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	MAP1B DYNC2H1 C1orf87 KNDC1 UBXN10 CFAP46	4.36e-05	185	153	6	5e689c2fb36ce3ac2adc8d15f67107f21cf68868
ToppCell	droplet-Liver-LIVER_HEP-30m-Endothelial-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CUL7 TUBGCP6 RUNDC3A HECW2 TRIM56 DOCK6	4.36e-05	185	153	6	bdd2e6cb20294b39a9d856004bf57ba69cf877e2
ToppCell	5'-GW_trimst-2-LargeIntestine-Neuronal-neuron_precursor\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CHD7 RUNDC3A PTPRZ1 MAST1 KCNQ2 CHD6	4.77e-05	188	153	6	9fd262bbf6cdebfd945e39428a6059726fb55b3a
ToppCell	3'-GW_trimst-1-LargeIntestine-Neuronal-neurons_A-Branch_A3_(IPAN/IN)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CACNA1E ISLR2 ARPP21 MAP1B RUNDC3A PAX2	4.77e-05	188	153	6	bd091503f580dedab40e0996273101285d24b586
ToppCell	Influenza_Severe-RBC\|World / Disease group and Cell class	ANK1 PAGE2 KANK2 RUNDC3A FLCN PAGE2B	4.77e-05	188	153	6	f0438e6a77ee1f0456cb65926685266fff470983
ToppCell	5'-GW_trimst-2-LargeIntestine-Neuronal-neuron_precursor-Neuroblast\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CHD7 RUNDC3A PTPRZ1 MAST1 KCNQ2 CHD6	4.77e-05	188	153	6	459e3fd4335a6f25f982d011b38702f4fcfed1cd
ToppCell	COVID-19-Heart\|COVID-19 / Disease (COVID-19 only), tissue and cell type	SYNPO2 MAP1B OBSCN MYLK3 XIRP2 TBX20	5.05e-05	190	153	6	918ad5037881212008f9f69d5df5da91fd01422c
ToppCell	severe_COVID-19-RBC\|severe_COVID-19 / disease group, cell group and cell class (v2)	ANK1 PAGE2 KANK2 RUNDC3A FLCN PAGE2B	5.05e-05	190	153	6	3a5723c2daf58c1932edd70910db4b8b30f63f42
ToppCell	Myeloid-Myeloid-C_(Cd16+_Monocyte)\|Myeloid / shred on cell class and cell subclass (v4)	NAB1 CLIP1 PTPRJ FAM169A FAM43A	5.25e-05	117	153	5	d1936e76a935216783a73ab414e4147fa48e68eb
ToppCell	severe_COVID-19-RBC\|World / disease group, cell group and cell class (v2)	ANK1 PAGE2 KANK2 RUNDC3A FLCN PAGE2B	5.36e-05	192	153	6	1b4e28fd2e3d70ab48dbe96b280d35395889fbe2
ToppCell	(210)_NKT_cell\|World / immune cells in Peripheral Blood (logTPM normalization)	BCL9L SH2D2A NFATC3 TRIM56 MACF1 RORA	5.36e-05	192	153	6	08dc0c019c594da7b9944db8fd706aa7780e6ae9
ToppCell	(21)_NKT_cell\|World / immune cells in Peripheral Blood (logTPM normalization)	BCL9L SH2D2A NFATC3 TRIM56 MACF1 RORA	5.36e-05	192	153	6	b0a573ddde2978485a857b8261ee1ee5ef68ecef
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SYNPO2 ARPP21 MAGI3 CAMKK2 TBR1 ANKRD33B	5.36e-05	192	153	6	5c7e8b80b44d9ce55c797cdf8267ac5382e26cac
ToppCell	Control-Endothelial-Endothelial-Gen_Cap\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	RUNDC3B ITPKB DACH2 HECW2 SBF2 TCF7L1	5.51e-05	193	153	6	e1d546165dcc2392f540162206852c4717d7306f
ToppCell	wk_20-22-Epithelial-Proximal_epithelial-MUC16+_ciliated\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	ABCA13 C1orf87 PLEKHS1 KNDC1 UBXN10 CFAP46	5.67e-05	194	153	6	756082a0f5953b52229bb60d40b84701cb6cb23d
ToppCell	moderate-Epithelial-FOXN4+\|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	DYNC2H1 ABCA13 E2F7 PLEKHS1 WDR90 CFAP46	5.67e-05	194	153	6	5dffa578149104dda33774361e9e77b227b5f1ce
ToppCell	LPS-IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	RUNDC3B ITPKB DACH2 HECW2 MACF1 DOCK6	5.67e-05	194	153	6	0b9cd96fa0b616da7cc90e92ff71157e9bba518f
ToppCell	T/NK_cells-CD8+_Naive_T_cell\|World / Lineage and Cell class	HLA-E HLA-F RNF213 SH2D2A RORA ATM	5.84e-05	195	153	6	43f11068beea076e9caeb1572215c3f65c9308e1
ToppCell	COVID_non-vent-Lymphocytic-T_cell\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	OBSCN ITPKB GOLGA8B MACF1 RORA ATM	5.84e-05	195	153	6	4bdedd924564a260841a9153604026b57487c83d
ToppCell	3'-GW_trimst-1-SmallIntestine-Neuronal-neurons_A-Branch_A3_(IPAN/IN)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ISLR2 CUX2 ARPP21 GARNL3 MAP1B RUNDC3A	5.84e-05	195	153	6	5a6a5048af638872700b76b7c71a8fa3fb8d3772
ToppCell	COVID-19_Severe-Lymphoid_T/NK-gd_T\|COVID-19_Severe / Disease group, lineage and cell class	HLA-E RNF213 MACF1 RORA ATM PDZD4	5.84e-05	195	153	6	9990440bda7fac5d00ef80444fab07459be625e1
ToppCell	PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	HLA-E RNF213 MACF1 RORA ATM PDZD4	6.01e-05	196	153	6	418e8e0a51c5cb60e3b903e7d2d800dc8b9f3d5c
ToppCell	PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HLA-E RNF213 MACF1 RORA ATM PDZD4	6.01e-05	196	153	6	581fc8c8d42005aacd7b401a2c9d1fc331fb4af7
ToppCell	wk_08-11-Epithelial-PNS-TM4SF4+_PENK+_neuron\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	ISLR2 ARPP21 MAP1B RUNDC3B RUNDC3A TBX20	6.01e-05	196	153	6	afa3a2f5f3a51d1830c6f95f97a4b3e13ed42512
ToppCell	PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	HLA-E RNF213 MACF1 RORA ATM PDZD4	6.01e-05	196	153	6	6beaf0c2799424c59819b286fbb5c1a83d85e4d1
ToppCell	PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HLA-E RNF213 MACF1 RORA ATM PDZD4	6.01e-05	196	153	6	c35f2349dfe35baa845f790b9f31673dceac54c0
ToppCell	3'-GW_trimst-1-SmallIntestine-Neuronal-neuron_precursor\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CHD7 RUNDC3A PTPRZ1 KCNQ2 JPT1 CHD6	6.18e-05	197	153	6	1378bf90a4b80b8166ef352c282ce51b114ba693
ToppCell	PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_Tem\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	HLA-E HLA-F RNF213 MACF1 RORA PDZD4	6.18e-05	197	153	6	2b3a56bb1d40bc1284a5931c4e7b373660de5402
ToppCell	COVID-19_Severe-Lymphoid_T/NK-CD8+_Tem\|COVID-19_Severe / Disease group, lineage and cell class	HLA-E HLA-F RNF213 MACF1 RORA PDZD4	6.18e-05	197	153	6	f0bac4d5c3160933ac3786cec8dadffb35d711ea
ToppCell	PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_Tem-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	HLA-E HLA-F RNF213 MACF1 RORA PDZD4	6.18e-05	197	153	6	f73ece3aca28c0db5db0f12e026d42c6c36b9efb
ToppCell	PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_Tem\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HLA-E HLA-F RNF213 MACF1 RORA PDZD4	6.18e-05	197	153	6	e70e7d97823a762def3970d94a0e897981a6c922
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	HLA-E STARD9 HECW2 DOCK6 TCF7L1 IL4R	6.18e-05	197	153	6	0f467ef58f0c4dcc00b34b7b9639e03fb3ebe780
ToppCell	PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_Tem-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HLA-E HLA-F RNF213 MACF1 RORA PDZD4	6.18e-05	197	153	6	bce0135a96910d2bace62a3408a1a6fdac0cf0df
ToppCell	severe_COVID-19-CD4+_CTL\|severe_COVID-19 / disease group, cell group and cell class (v2)	BCL9L HLA-F RNF213 SH2D2A RORA PDZD4	6.18e-05	197	153	6	e51b7cd03b1450dc8601b4be0453b104d6a5f955
ToppCell	COVID_vent-Lymphocytic-T_cell-CD8+_Memory_T_cell\|COVID_vent / Disease condition, Lineage, Cell class and subclass	HLA-E RNF213 MACF1 RORA ATM PDZD4	6.18e-05	197	153	6	d4dfb3b561d0783cdbee4e8d27009ad81df695cb
ToppCell	10x_3'_v3-blood_(10x_3'_v3)-lymphocytic-innate_lymphocytic-mature_NK_T_cell\|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	HLA-F SH2D2A MACF1 RORA ATM PDZD4	6.35e-05	198	153	6	c54da37aa11f82a68e591d563b3db9121d6b498f
ToppCell	10x_3'_v3-blood_(10x_3'_v3)-lymphocytic-T_lymphocytic-type_I_NK_T_cell\|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	HLA-F GOLGA8B MACF1 RORA ATM PDZD4	6.35e-05	198	153	6	58d805e827299292750b09c6283fdbe406b75f79
ToppCell	10x_3'_v3-blood_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD8-positive,_alpha-beta_cytokine_secreting_effector_T_cell\|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	HLA-F GOLGA8B MACF1 RORA ATM GOLGA4	6.35e-05	198	153	6	34c564ece9a2b94dcf646e3c95b5be9c5ecfaafe
ToppCell	10x_3'_v3-blood_(10x_3'_v3)-lymphocytic-innate_lymphocytic\|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	HLA-F SH2D2A MACF1 RORA ATM PDZD4	6.35e-05	198	153	6	90023468f3498548a92d75928f476b4157bde813
ToppCell	3'-GW_trimst-1-SmallIntestine-Neuronal-neurons_A-Branch_A1_(iMN)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ISLR2 MAP1B CHD7 RUNDC3A KCNQ2 JPT1	6.35e-05	198	153	6	dac7b68bb8f1c4d8aa7fdfada61f79956866e874
ToppCell	3'-GW_trimst-1-SmallIntestine-Neuronal\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MAP1B CHD7 RUNDC3A PTPRZ1 KCNQ2 JPT1	6.53e-05	199	153	6	86739a6f5e0fa7448389b97b3c4de41f2a7d7ebd
ToppCell	5'-GW_trimst-1.5-SmallIntestine-Neuronal\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MAP1B CHD7 RUNDC3A PTPRZ1 KCNQ2 JPT1	6.53e-05	199	153	6	f2410509007d35e948a88f127f613d0119e6a4c4
ToppCell	PBMC-Control-Lymphocyte-T/NK-NK_cell-NK\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HLA-E RNF213 SH2D2A MACF1 RORA PDZD4	6.53e-05	199	153	6	4820f5bcd7bc34c2ebf6a3422cc8eb383a3b5a4e
ToppCell	healthy_donor-Lymphocytic\|healthy_donor / Disease condition, Lineage, Cell class and subclass	RNF213 GOLGA8B MACF1 RORA ATM PDZD4	6.53e-05	199	153	6	2841e16d54acd344ba454f024e285c28abc37319
ToppCell	mild-MAIT\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	HLA-F RNF213 GOLGA8B MACF1 RORA GOLGA4	6.53e-05	199	153	6	cbe1fb6d2c5fca7a1baf1ad20afcdf8e8e11bd84
ToppCell	PBMC-Control-Lymphocyte-T/NK-NK_cell\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HLA-E RNF213 SH2D2A MACF1 RORA PDZD4	6.53e-05	199	153	6	eb05ccae5187e4701bbbe6d714a6d2808fbcf306
ToppCell	PBMC-Control-Lymphocyte-T/NK-NK_cell\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	HLA-E RNF213 SH2D2A MACF1 RORA PDZD4	6.53e-05	199	153	6	10c8729b779073c3bf808e85958d59147f0be5c5
ToppCell	Tracheal-NucSeq\|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations	AMBRA1 MAGI3 PTPRJ SBF2 RORA HERC1	6.53e-05	199	153	6	94b94b17ca18b8dc27b91da1f2ccf89e03cc7035
ToppCell	PBMC-Control-Lymphocyte-T/NK-NK_cell-NK-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HLA-E RNF213 SH2D2A MACF1 RORA PDZD4	6.53e-05	199	153	6	867fd292f3879982422e840e087bfdb3b21a8715
ToppCell	PBMC-Control-Lymphocyte-T/NK-NK_cell-NK-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	HLA-E RNF213 SH2D2A MACF1 RORA PDZD4	6.53e-05	199	153	6	5e9fe852a70546c9d235414a2c26ca3e67ba6eb9
ToppCell	Control-Lymphoid_T/NK-NK\|Control / Disease group, lineage and cell class	HLA-E RNF213 SH2D2A MACF1 RORA PDZD4	6.53e-05	199	153	6	94b2693a8378b9b2c58c6aebb2c6658d75b2e3de
Computational	Neighborhood of RAP1B	HLA-E HLA-F RETREG3 ELF4	8.30e-05	36	70	4	GNF2_RAP1B
Computational	Neighborhood of HLA-C	HLA-E HLA-F ELF4 ARHGAP45	2.38e-04	47	70	4	GNF2_HLA_C
Computational	Genes upregulated in subsets of cells of a given type within various tumors	MACF1 RORA ATM GOLGA4	2.80e-04	49	70	4	GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CHROMATIN
Disease	total blood protein measurement	ZNF438 NCOA3 ESR1 C4orf17 NFATC3 SBF2 MACF1 RORA ARHGAP45 ANKRD33B TCF7L1	1.37e-05	449	144	11	EFO_0004536
Disease	breast carcinoma (is_marker_for)	NCOA3 ESR1 MDC1 ATM EP300	1.82e-05	66	144	5	DOID:3459 (is_marker_for)
Disease	congenital heart disease (implicated_via_orthology)	KMT2B CHD7 JPT1 CHD6 TBX20	2.26e-05	69	144	5	DOID:1682 (implicated_via_orthology)
Disease	Malignant neoplasm of breast	ZNF438 NCOA3 ANK1 DYNC2H1 C1orf87 ESR1 OBSCN CLIP1 ARFGAP3 MACF1 ZFYVE26 ATM TCF7L1 EP300 PDZD4 DNMT3B	7.45e-05	1074	144	16	C0006142
Disease	leukemia	NCOA3 ESR1 BAD ATM	1.53e-04	55	144	4	C0023418
Disease	Immunologic Deficiency Syndromes	CHD7 ATM DNMT3B	1.88e-04	23	144	3	C0021051
Disease	Prostatic Neoplasms	NCOA3 ESR1 PCDH11Y BAD CHD7 CAMKK2 CHD6 ATM HERPUD1 GOLGA4 DNMT3B	2.30e-04	616	144	11	C0033578
Disease	Malignant neoplasm of prostate	NCOA3 ESR1 PCDH11Y BAD CHD7 CAMKK2 CHD6 ATM HERPUD1 GOLGA4 DNMT3B	2.30e-04	616	144	11	C0376358
Disease	Colorectal cancer	PTPRJ FLCN EP300	3.06e-04	27	144	3	cv:C0346629
Disease	COLORECTAL CANCER	PTPRJ FLCN EP300	3.06e-04	27	144	3	114500
Disease	Neoplasm of the large intestine	PTPRJ FLCN EP300	3.06e-04	27	144	3	cv:C0009404
Disease	glucagon measurement, glucose tolerance test	MACF1 HERC1	3.50e-04	6	144	2	EFO_0004307, EFO_0008463
Disease	Schizophrenia	ABCA13 ESR1 LAMA1 HLA-E OFCC1 AMBRA1 ITIH1 CAMKK2 PTPRZ1 BTC KCNQ2 ATM DNMT3B	4.05e-04	883	144	13	C0036341
Disease	CHARGE syndrome (implicated_via_orthology)	CHD7 CHD6	4.89e-04	7	144	2	DOID:0050834 (implicated_via_orthology)
Disease	graft-versus-host disease (implicated_via_orthology)	HLA-E HLA-F	4.89e-04	7	144	2	DOID:0081267 (implicated_via_orthology)
Disease	infertility (implicated_via_orthology)	ESR1 ATM	4.89e-04	7	144	2	DOID:5223 (implicated_via_orthology)
Disease	female breast cancer (is_implicated_in)	MAST1 ATM	6.50e-04	8	144	2	DOID:0050671 (is_implicated_in)
Disease	Colorectal Carcinoma	CCDC9B MAP1B TCOF1 ABCA13 LAMA1 OBSCN GJD4 MYLK3 PCDH11X FLCN EP300	6.86e-04	702	144	11	C0009402
Disease	hypertension	CUX2 ANK1 RNF213 TTBK1 PTPRJ SBF2 TBX20	8.04e-04	307	144	7	EFO_0000537
Disease	lactosyl-N-nervonoyl-sphingosine (d18:1/24:1) measurement	CHD7 HERPUD1	8.33e-04	9	144	2	EFO_0800517
Disease	Dystonia	CACNA1E KMT2B KCNQ2 ATM	8.47e-04	86	144	4	C0013421
Disease	carpal tunnel syndrome	ZNF438 KANK2 ITIH1 ZBTB34	9.63e-04	89	144	4	EFO_0004143
Disease	eosinophil percentage of leukocytes	KMT2B CHD7 ITPKB SBF2 ANAPC2 RORA ATM ARHGAP45 ANKRD33B IL4R FAM43A	1.12e-03	746	144	11	EFO_0007991
Disease	meningitis	CACNA1E ITPKB	1.26e-03	11	144	2	MONDO_0021108
Disease	Adenocarcinoma of large intestine	CAMKK2 FLCN ATM EP300	1.28e-03	96	144	4	C1319315
Disease	immunoglobulin isotype switching measurement	CUX2 ITIH1 ARHGAP45	1.30e-03	44	144	3	EFO_0010128
Disease	Intellectual Disability	CACNA1E CUX2 MAP1B LAMA1 TRMT1 FHIP2A MACF1 RORA	1.63e-03	447	144	8	C3714756
Disease	blood urea nitrogen measurement	SYNPO2 CUX2 OFCC1 TRMT1 NFATC3 RORA WDR90 TCF7L1	1.75e-03	452	144	8	EFO_0004741
Disease	Bipolar Disorder	CUX2 ABCA13 ESR1 HLA-E ITIH1 STARD9 KCNQ2 RORA	2.44e-03	477	144	8	C0005586
Disease	Alzheimer disease	OFCC1 ITIH1 RNF6 DACH2 TRIM56 PCDH11X PAX2 ARHGAP45	2.71e-03	485	144	8	MONDO_0004975
Disease	colorectal cancer (is_implicated_in)	PTPRJ FLCN ATM EP300	2.97e-03	121	144	4	DOID:9256 (is_implicated_in)
Disease	sleep duration, high density lipoprotein cholesterol measurement	ZNF438 MACF1 DOCK6 HERPUD1	2.97e-03	121	144	4	EFO_0004612, EFO_0005271
Disease	MAJOR AFFECTIVE DISORDER 2	CUX2 KCNQ2	3.07e-03	17	144	2	C1839839
Disease	pulse pressure measurement	ZNF438 CUX2 MAP1B DYNC2H1 ESR1 NAB1 RNF213 ITIH1 TTBK1 CSNK1G3 SBF2 PAX2 TCF7L1 GOLGA4 DNMT3B	3.39e-03	1392	144	15	EFO_0005763
Disease	Female Urogenital Diseases	ESR1 PAX2	3.44e-03	18	144	2	C1720887
Disease	Malignant Neoplasms	ESR1 PLEKHS1 ATM ARHGAP45	3.64e-03	128	144	4	C0006826
Disease	oral squamous cell carcinoma (is_marker_for)	ATM DOCK6 DNMT3B	3.65e-03	63	144	3	DOID:0050866 (is_marker_for)
Disease	serum IgE measurement	SYNPO2 RORA IL4R	3.82e-03	64	144	3	EFO_0004579
Disease	Central precocious puberty	ESR1 OFCC1	3.83e-03	19	144	2	EFO_0009029
Disease	dense area measurement, mammographic density measurement	ESR1 BTC	3.83e-03	19	144	2	EFO_0005941, EFO_0006503
Disease	Hereditary Non-Polyposis Colon Cancer Type 2	PTPRJ ATM	3.83e-03	19	144	2	C1333991
Disease	Colorectal cancer, hereditary nonpolyposis, type 1	PTPRJ ATM	3.83e-03	19	144	2	C2936783
Disease	Benign Neoplasm	PLEKHS1 ATM ARHGAP45	4.52e-03	68	144	3	C0086692
Disease	Neoplasms	PLEKHS1 ATM ARHGAP45	4.52e-03	68	144	3	C0027651
Disease	BREAST CANCER	ESR1 ATM	4.67e-03	21	144	2	114480
Disease	in situ carcinoma (is_marker_for)	ESR1 PDPN	4.67e-03	21	144	2	DOID:8719 (is_marker_for)

Protein segments in the cluster

Peptide	Gene	Start	Entry
VGTEGSVPSDDQDRE	ESX1	61	Q8N693
NEIQGESVSLGDDPS	EP300	1206	Q09472
GTQSEDQRPAGAASE	C16orf86	51	Q6ZW13
TSRPVETTLENNEGG	ARFGAP3	176	Q9NP61
PASLETGQDSEDDSG	ANAPC2	461	Q9UJX6
DGDSDQSRNRQGTPV	CACNA1E	16	Q15878
ESPQVEADSGDGDSS	DNMT3B	201	Q9UBC3
QPSLGEGEESESNSV	AAMP	306	Q13685
EQEDSSSAERGLGPS	BAD	11	Q92934
GESLLASGESQQSPE	CTSL3P	156	Q5NE16
TDNPRDSGEGDTTSL	ANK1	1156	P16157
GSDGERVAQTPDSSD	FBXO10	341	Q9UK96
PRLGTEEQGTNEDVS	CFAP46	876	Q8IYW2
SSLQNREGELEGSAP	ABCA13	3826	Q86UQ4
ENLVESDEGESPGSS	AP1AR	46	Q63HQ0
SSDNQGPSVEGTDLE	AMBRA1	761	Q9C0C7
NSLSGTQEDGLDDPR	LRPAP1	136	P30533
ENQQPEGRSSSSLSG	CUX2	1011	O14529
GSQNGTESEPDDLNS	DACH2	241	Q96NX9
SEESSQPEAGAVSRG	CHD7	2251	Q9P2D1
SARPGGESLQDQESI	ARPP21	76	Q9UBL0
EDIGQSPSGTTNEDA	C1orf87	161	Q8N0U7
TGQEDADSREGSPRA	ANKRD33B	371	A6NCL7
AEQGDPSGDLQREES	ISLR2	681	Q6UXK2
PEEATQVDSNGRTGL	ANKRD33	121	Q7Z3H0
SDDGGATPVQDERDS	IWS1	11	Q96ST2
ATPVQDERDSGSDGE	IWS1	16	Q96ST2
TQDTELVETRPAGDG	HLA-F	246	P30511
RNEGTSSSAPVLEEG	SLC34A3	26	Q8N130
VAESTEEPAGSNRGQ	HERPUD1	101	Q15011
VNSVNGDLGSPSDDE	HECW2	341	Q9P2P5
DGESSGANDSLRTPE	PTPRJ	86	Q12913
TQDTELVETRPAGDG	HLA-E	246	P13747
TPGGQDESSNQRAEV	ARHGAP45	981	Q92619
NNSTLTISGIGPEDE	IGDCC3	381	Q8IVU1
PGGSESEATASDEEN	MAP1B	1091	P46821
RQSDEGSSNQEEEGP	MAGEA2	81	P43356
SQSDEGSSSNEEEGP	MAGEA8	81	P43361
DTDTLGESTQPQREG	MDC1	651	Q14676
DGLNGPSDASEQRVS	MAGI3	551	Q5TCQ9
STEGRELTQGPAESS	FLCN	316	Q8NFG4
LTDGDPTEGVTDRSQ	ITIH1	401	P19827
SEDSDLAGEAGPRSQ	SBF2	1606	Q86WG5
LTSDNSDGQGERPLN	NAB1	411	Q13506
PDALNRAGDTSDQEG	ELF4	141	Q99607
EVSSQGPEDSLLGTQ	GMIP	846	Q9P107
LDEGTPNRESGDTQS	GOLGA4	46	Q13439
STPQRSLRDSDGEDG	FOXD4L4	11	Q8WXT5
STPQRSLRDSDGEDG	FOXD4L3	11	Q6VB84
NSRTVSVEGDAPGSD	IQSEC2	241	Q5JU85
VSSTNGELNVDDPTG	CSNK1G1	371	Q9HCP0
EDSESGEAQLSPQAG	FAM13B	491	Q9NYF5
NRLEGDAEESLGSPS	HERC1	3471	Q15751
REAAQDPRGSGSEEQ	GJD4	316	Q96KN9
EGQEGSQSTRETPSE	CCDC9B	351	Q6ZUT6
PINITASGTGQDDAD	NHSL1	221	Q5SYE7
APTSRGGASVEETDQ	ESR1	551	P03372
AASRQNSEEASLPGE	KCNQ2	501	O43526
STSGVQSDAREPGEE	MYLK3	176	Q32MK0
SNSQELDSGVGRTDE	PDZD4	271	Q76G19
AQNTSAPEELSGERG	CUL7	276	Q14999
ENVDTDLPGSLGQSE	JPT1	106	Q9UK76
REVEEELATSGGQSP	MACF1	1706	O94854
GPAGNRTVNREDSDE	KIR2DS3	281	Q14952
SSERGNDQESSQPVG	PAGE2B	11	Q5JRK9
DTAAQSSPGRGEEAE	TUBGCP6	1391	Q96RT7
DGTDSEAEAVQQPRG	KMT2B	2066	Q9UMN6
RQEENPSTSLDSNGA	PTPRZ1	2286	P23471
LISVQDPDSGSNGDV	PCDHGC4	371	Q9Y5F7
DRATPSNRTEGDGNS	PCDH11X	1096	Q9BZA7
SNRTEGDGNSDPEST	PCDH11X	1101	Q9BZA7
STPQRSLRDSDGEDG	FOXD4	11	Q12950
AEVNRASTEGESPDG	GOLGA3	46	Q08378
REASSSSPEAGEGQI	ISCA2	36	Q86U28
SSPEAGEGQIRLTDS	ISCA2	41	Q86U28
GELNTDDPTAGRSNA	CSNK1G3	401	Q9Y6M4
SRLAQQRGDSEDGSP	C17orf75	46	Q9HAS0
SGGSNTPEQDDLSEG	MAST1	346	Q9Y2H9
TLRDVSEGSVPNGDS	PAX2	226	Q02962
GPAGNRTVNREDSDE	KIR2DS5	281	Q14953
EQEGTESTTDEGQLP	OBSCN	5246	Q5VST9
NSGVRPDVNESESGS	ALPI	421	P09923
SRQGEPQDESGREET	OFCC1	131	Q8IZS5
GREETLNSEAPGSSN	OFCC1	141	Q8IZS5
ASQEVSTPSQARGEG	C6orf132	721	Q5T0Z8
NIDTSSEDPGNTESG	DYNC2H1	1576	Q8NCM8
VSDANEPGESQSTIG	ATM	866	Q13315
QEQATDPLVDSLGSG	IL4R	696	P24394
RQSGDGQESTEPVEN	CASC3	146	O15234
LQEGPASGSGSERDD	E2F7	561	Q96AV8
QDASGDERSGPEDSN	DOCK6	156	Q96HP0
VTDGTSDIPERGNTD	CHD6	1326	Q8TD26
DIPRNESSDSALGDS	FNIP2	886	Q9P278
DTEGDQPTRVSSQGS	C4orf17	271	Q53FE4
SGEQREAGTPSLDSE	BCL9L	121	Q86UU0
SEPEGSNNEASDRGS	CTR9	1151	Q6PD62
SPNTTSSLEDQGEEG	FAM169A	561	Q9Y6X4
GDSSRQADGASADEP	FAM43A	406	Q8N2R8
STPQRSLRDSDGEDG	FOXD4L1	11	Q9NU39
ADGQEVPLDTSGSQA	CAMKK2	76	Q96RR4
IPTAEGASGSNTEEE	KANK2	571	Q63ZY3
GSAGQPRSEDEDSLE	KLHDC4	406	Q8TBB5
EEAGSQLEGSQSPRS	KNDC1	971	Q76NI1
GQDSLSTDTGQSRQP	FHIP2A	196	Q5W0V3
STDTGQSRQPEELSG	FHIP2A	201	Q5W0V3
SVEPAQGEAREGSSQ	GOLGA8B	546	A8MQT2
QGEAREGSSQDNPTA	GOLGA8B	551	A8MQT2
ADGNSTRSPETNGLL	BTC	31	P35070
SGSLTNTPERGSDED	MFSD14B	466	Q5SR56
EDEANGLQTTPASRA	CLIP1	131	P30622
VENGSSDENATALPG	GARNL3	66	Q5VVW2
PSGTTDADQDLDGSD	MIER2	366	Q8N344
RETGDGDPVSNISQT	PRR14L	1361	Q5THK1
DRATPSNRTEGDGNS	PCDH11Y	1091	Q9BZA8
SNRTEGDGNSDPEST	PCDH11Y	1096	Q9BZA8
SSERGNDQESSQPVG	PAGE2	11	Q7Z2X7
SGEQNEPARESLSSG	HSF2	301	Q03933
SDSQRLGEGTRDEEP	RUNDC3A	381	Q59EK9
SQTSLDPGQSQEGDG	RUNDC3B	401	Q96NL0
ESENLASGDQPRTAA	TRMT1	131	Q9NXH9
SSGAGSQPEAQRELD	TRMT44	166	Q8IYL2
EVNEDGTEDTSQPGR	TBR1	341	Q16650
SNTGNAERAEEVPGE	SH2D2A	51	Q9NP31
GSESEEEAPAGTRSQ	TCOF1	276	Q13428
TQEDGALEETQGSPR	ITPKB	576	P27987
EGASTGQPEDDTETT	PDPN	21	Q86YL7
STPQRSLRDSDGEDG	FOXD4L5	11	Q5VV16
STPQRSLRDSDGEDG	FOXD4L6	11	Q3SYB3
QGETPGASSDLNRLD	LAMA1	2416	P25391
SSVEGAENQRGPLES	NCOA3	601	Q9Y6Q9
DAEALSERSGNTPNS	SPDL1	541	Q96EA4
SRGAGDLDSNPGEDT	SPPL2C	566	Q8IUH8
SRSDGGSEETLPQDH	RNF6	6	Q9Y252
QSSSDQTRNEGEAPG	STARD9	2601	Q9P2P6
LGETEEGSIENTPSQ	SMCR8	566	Q8TEV9
NLSRGQTPLTEGSED	RETREG3	301	Q86VR2
NVGERSPDQSEHTDG	TNIP2	181	Q8NFZ5
LDSINNGSPDEGDIS	XIRP2	411	A4UGR9
SDSGESIETDGPDQV	PLEKHS1	226	Q5SXH7
RAGPSDSNLDGTVTE	RNF213	4431	Q63HN8
LNPSRQEDEESTGLG	ZNF341	396	Q9BYN7
LSQERSDASNADGPG	WDR90	296	Q96KV7
EGSERSTDRSQEGAP	TTBK1	791	Q5TCY1
GPSETTESNTAEGER	ZNF804B	906	A4D1E1
ESSPRELEDSSGDQG	TRMT61B	96	Q9BVS5
GTPSREQDAAQTDGL	SYNPO2	516	Q9UMS6
GEEQEPSSDSASAQR	TCF7L1	46	Q9HCS4
DAAAGSRETPLNQES	RORA	21	P35398
LSEDENPDANGVTRS	SUN3	31	Q8TAQ9
NGEAASTSRPLETQG	nan	106	A8MX80
SPARETSIDDGLGSQ	NFATC3	366	Q12968
NGEAASTSRPLETQG	nan	76	A8MV72
NGEAASTSRPLETQG	nan	106	Q8N9G6
AGGNPRSLENSLDEE	ZNF496	336	Q96IT1
NGEAASTSRPLETQG	nan	106	A8MUA0
EDVLGDESQTTPNRG	TBX20	321	Q9UMR3
QGSSRAGNLEEPSDQ	UBXN10	181	Q96LJ8
AEPSSQEGGDTDLRS	ZNF295-AS1	106	Q8N0V1
LPSQVEDTLSGEEGN	TLDC2	11	A0PJX2
EEGNSSSETGELPVQ	TCHHL1	556	Q5QJ38
DEGESNIPSGTIQSR	ZNF438	11	Q7Z4V0
QADGRDRGSNPSLES	ZFYVE26	776	Q68DK2
GTTAVSSNRNPEDDG	nan	136	Q8N7P7
SEREQDGDPRGLQSS	THEG	21	Q9P2T0
TQGGEESQSRREDEP	TRIM56	386	Q9BRZ2
SVTVGAEENPESRNG	ZBTB34	136	Q8NCN2
TSQETFGEEDPQGSE	ZNF34	126	Q8IZ26
LLQPQAETGSGTESD	NACA4P	16	Q9BZK3